Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Macrogenics (MGNX) Revenue (2016 - 2025)

Historic Revenue for Macrogenics (MGNX) over the last 14 years, with Q3 2025 value amounting to $72.8 million.

  • Macrogenics' Revenue fell 3420.62% to $72.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $148.3 million, marking a year-over-year increase of 1078.96%. This contributed to the annual value of $150.0 million for FY2024, which is 15525.88% up from last year.
  • Latest data reveals that Macrogenics reported Revenue of $72.8 million as of Q3 2025, which was down 3420.62% from $22.2 million recorded in Q2 2025.
  • Macrogenics' 5-year Revenue high stood at $110.7 million for Q3 2024, and its period low was $3.3 million during Q2 2024.
  • In the last 5 years, Macrogenics' Revenue had a median value of $16.9 million in 2021 and averaged $29.4 million.
  • Its Revenue has fluctuated over the past 5 years, first plummeted by 8533.5% in 2023, then surged by 96480.72% in 2024.
  • Over the past 5 years, Macrogenics' Revenue (Quarter) stood at $14.1 million in 2021, then soared by 416.71% to $73.1 million in 2022, then crashed by 85.33% to $10.7 million in 2023, then skyrocketed by 273.13% to $40.0 million in 2024, then skyrocketed by 82.1% to $72.8 million in 2025.
  • Its last three reported values are $72.8 million in Q3 2025, $22.2 million for Q2 2025, and $13.2 million during Q1 2025.